MM
GILD icon

MQS Management’s Gilead Sciences GILD Stock Holding History

MQS Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,189
Closed -$391K – 470
2025
Q4 		$391K Sell
3,189
-108
-3% -$13.1K 0.23% 176
2025
Q3 		$366K Buy
+3,297
New +$375K 0.21% 195
2024
Q3 		– Sell
-4,573
Closed -$314K – 525
2024
Q2 		$314K Buy
4,573
+1,157
+34% +$77.2K 0.19% 230
2024
Q1 		$250K Buy
+3,416
New +$263K 0.14% 314
2023
Q4 		– Sell
-5,918
Closed -$443K – 537
2023
Q3 		$443K Buy
5,918
+2,185
+59% +$168K 0.27% 141
2023
Q2 		$288K Buy
+3,733
New +$298K 0.2% 234
2022
Q3 		– Sell
-4,080
Closed -$252K – 483
2022
Q2 		$252K Sell
4,080
-5,266
-56% -$326K 0.17% 260
2022
Q1 		$556K Buy
+9,346
New +$597K 0.45% 49

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MQS Management's GILD Position: Q1 2026 in Review

MQS Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 3,189 shares — an estimated $391K sold.

MQS Management first reported a position in GILD in Q1 2022 and held it in 8 quarters. The position peaked at $556K in Q1 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • MQS Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • MQS Management sold 3,189 Gilead Sciences shares in Q1 2026, an estimated $391K.
  • MQS Management first reported a position in Gilead Sciences in Q1 2022 and held it in 8 quarters.
  • MQS Management's Gilead Sciences position peaked at $556K in Q1 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on MQS Management's 13F filing for Q1 2026, filed 23 Apr 2026.